Tennessee Valley Asset Management Partners Charles River Laboratories International, Inc. Transaction History

Tennessee Valley Asset Management Partners

$594 Million
Q4 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Jan 29, 2024	BUY	$164.52 - $238.84 $2,467 - $3,582	15 New	15 $3,000

Others Institutions Holding CRL

# of Institutions

710

Shares Held

53.9M

Call Options Held

122K

Put Options Held

239K

Vanguard Group Inc Valley Forge, PA

6.16M
Shares

$1.02 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$841 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

4.08M
Shares

$674 Million
0.14% of portfolio
State Street Corp Boston, MA

2.18M
Shares

$361 Million
0.02% of portfolio
Allspring Global Investments Holdings, LLC

1.81M
Shares

$299 Million
0.56% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.41B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tennessee Valley Asset Management Partners, based on Form 13F filings with the SEC.

News

Stay updated on Tennessee Valley Asset Management Partners with notifications on news.

Account